Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Net Margin (2020 - 2025)

Historic Net Margin for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to 2654.92%.

  • iSpecimen's Net Margin fell 25906200.0% to 2654.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 366.36%, marking a year-over-year decrease of 2730900.0%. This contributed to the annual value of 138.39% for FY2024, which is 291500.0% down from last year.
  • Latest data reveals that iSpecimen reported Net Margin of 2654.92% as of Q3 2025, which was down 25906200.0% from 255.36% recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Net Margin ranged from a high of 48.04% in Q2 2021 and a low of 2654.92% during Q3 2025
  • In the last 5 years, iSpecimen's Net Margin had a median value of 94.64% in 2022 and averaged 256.2%.
  • As far as peak fluctuations go, iSpecimen's Net Margin soared by 1365400bps in 2024, and later tumbled by -25906200bps in 2025.
  • Quarter analysis of 5 years shows iSpecimen's Net Margin stood at 79.54% in 2021, then rose by 8bps to 72.92% in 2022, then crashed by -51bps to 109.83% in 2023, then plummeted by -270bps to 406.28% in 2024, then tumbled by -553bps to 2654.92% in 2025.
  • Its last three reported values are 2654.92% in Q3 2025, 255.36% for Q2 2025, and 154.85% during Q1 2025.